Literature DB >> 32172623

Effects of Chronic Nicotine Inhalation on Systemic and Pulmonary Blood Pressure and Right Ventricular Remodeling in Mice.

Joshua M Oakes1, Jiaxi Xu2,3, Tamara M Morris2,3, Nicholas D Fried1, Charlotte S Pearson1, Thomas D Lobell1,3, Nicholas W Gilpin1,3, Eric Lazartigues2,4,3, Jason D Gardner1,4, Xinping Yue1.   

Abstract

Cigarette smoking is the single most important risk factor for the development of cardiovascular and pulmonary diseases; however, the role of nicotine in the pathogenesis of these diseases is incompletely understood. The purpose of this study was to examine the effects of chronic nicotine inhalation on the development of cardiovascular and pulmonary disease with a focus on blood pressure and cardiac remodeling. Male C57BL6/J mice were exposed to air (control) or nicotine vapor (daily, 12 hour on/12 hour off) for 8 weeks. Systemic blood pressure was recorded weekly by radio-telemetry, and cardiac remodeling was monitored by echocardiography. At the end of the 8 weeks, mice were subjected to right heart catheterization to measure right ventricular systolic pressure. Nicotine-exposed mice exhibited elevated systemic blood pressure from weeks 1 to 3, which then returned to baseline from weeks 4 to 8, indicating development of tolerance to nicotine. At 8 weeks, significantly increased right ventricular systolic pressure was detected in nicotine-exposed mice compared with the air controls. Echocardiography showed that 8-week nicotine inhalation resulted in right ventricular (RV) hypertrophy with increased RV free wall thickness and a trend of increase in RV internal diameter. In contrast, there were no significant structural or functional changes in the left ventricle following nicotine exposure. Mechanistically, we observed increased expression of angiotensin-converting enzyme and enhanced activation of mitogen-activated protein kinase pathways in the RV but not in the left ventricle. We conclude that chronic nicotine inhalation alters both systemic and pulmonary blood pressure with the latter accompanied by RV remodeling, possibly leading to progressive and persistent pulmonary hypertension.

Entities:  

Keywords:  angiotensin-converting enzyme; blood pressure; hypertension; hypertension, pulmonary; nicotine

Mesh:

Substances:

Year:  2020        PMID: 32172623      PMCID: PMC7145734          DOI: 10.1161/HYPERTENSIONAHA.119.14608

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

Review 1.  Smoking and chronic obstructive pulmonary disease.

Authors:  J M Sethi; C L Rochester
Journal:  Clin Chest Med       Date:  2000-03       Impact factor: 2.878

2.  Persistent blood pressure increase induced by heavy smoking.

Authors:  A Groppelli; D M Giorgi; S Omboni; G Parati; G Mancia
Journal:  J Hypertens       Date:  1992-05       Impact factor: 4.844

Review 3.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 4.  Right versus left ventricular failure: differences, similarities, and interactions.

Authors:  Mark K Friedberg; Andrew N Redington
Journal:  Circulation       Date:  2014-03-04       Impact factor: 29.690

Review 5.  The renin-angiotensin system and experimental heart failure.

Authors:  K C Wollert; H Drexler
Journal:  Cardiovasc Res       Date:  1999-09       Impact factor: 10.787

6.  Blood pressure in smokers and nonsmokers: epidemiologic findings.

Authors:  M S Green; E Jucha; Y Luz
Journal:  Am Heart J       Date:  1986-05       Impact factor: 4.749

7.  Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.

Authors:  Ming-Sheng Zhou; Kiranmai Chadipiralla; Armando J Mendez; Edgar A Jaimes; Roy L Silverstein; Keith Webster; Leopoldo Raij
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-07       Impact factor: 4.733

8.  Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.

Authors:  Norbert Weissmann; Borja Lobo; Alexandra Pichl; Nirmal Parajuli; Michael Seimetz; Raquel Puig-Pey; Elisabet Ferrer; Víctor I Peinado; David Domínguez-Fandos; Athanasios Fysikopoulos; Johannes-Peter Stasch; Hossein A Ghofrani; Núria Coll-Bonfill; Reiner Frey; Ralph T Schermuly; Jéssica García-Lucio; Isabel Blanco; Mariola Bednorz; Olga Tura-Ceide; Elsa Tadele; Ralf P Brandes; Jan Grimminger; Walter Klepetko; Peter Jaksch; Robert Rodriguez-Roisin; Werner Seeger; Friedrich Grimminger; Joan A Barberà
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

Review 9.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 10.  Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.

Authors:  Kannaporn Intachai; Siriporn C Chattipakorn; Nipon Chattipakorn; Krekwit Shinlapawittayatorn
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

View more
  12 in total

Review 1.  The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.

Authors:  Lillian Truong; Yun-Min Zheng; Yong-Xiao Wang
Journal:  Biomedicines       Date:  2022-04-21

Review 2.  Nicotine and vascular dysfunction.

Authors:  Anna K Whitehead; Abigail P Erwin; Xinping Yue
Journal:  Acta Physiol (Oxf)       Date:  2021-02-24       Impact factor: 6.311

3.  Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.

Authors:  Nicholas D Fried; Tamara M Morris; Anna Whitehead; Eric Lazartigues; Xinping Yue; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-12       Impact factor: 4.733

4.  Sex-Dependent Effects of Inhaled Nicotine on the Gut Microbiome.

Authors:  Anna K Whitehead; Margaret C Meyers; Christopher M Taylor; Meng Luo; Scot E Dowd; Xinping Yue; Lauri O Byerley
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

5.  Alamandine alleviates hypertension and renal damage via oxidative-stress attenuation in Dahl rats.

Authors:  Juexiao Gong; Man Luo; Yonghong Yong; Shan Zhong; Peng Li
Journal:  Cell Death Discov       Date:  2022-01-12

Review 6.  Role of environmental toxicants in the development of hypertensive and cardiovascular diseases.

Authors:  Ehsan Habeeb; Saad Aldosari; Shakil A Saghir; Mariam Cheema; Tahani Momenah; Kazim Husain; Yadollah Omidi; Syed A A Rizvi; Muhammad Akram; Rais A Ansari
Journal:  Toxicol Rep       Date:  2022-03-22

7.  TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients.

Authors:  Wenjun He; Chunli Liu; Jing Liao; Fei Liu; Hui Lei; Danmei Wei; Honglian Ruan; Bibhav Kunwar; Wenju Lu; Jian Wang; Tao Wang
Journal:  Front Med (Lausanne)       Date:  2022-02-25

8.  α7 Nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension.

Authors:  Alexander Vang; Denielli da Silva Gonçalves Bos; Ana Fernandez-Nicolas; Peng Zhang; Alan R Morrison; Thomas J Mancini; Richard T Clements; Iuliia Polina; Michael W Cypress; Bong Sook Jhun; Edward Hawrot; Ulrike Mende; Jin O-Uchi; Gaurav Choudhary
Journal:  JCI Insight       Date:  2021-06-22

Review 9.  Secondary Metabolites of Plants as Modulators of Endothelium Functions.

Authors:  Anna Bartáková; Marie Nováková
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

10.  Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction.

Authors:  Anand Ramalingam; Siti Balkis Budin; Norsyahida Mohd Fauzi; Rebecca H Ritchie; Satirah Zainalabidin
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.